Avadel Pharmaceuticals (AVDL) Deferred Taxes: 2009-2022
Historic Deferred Taxes for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Dec 2022 value amounting to -$51.9 million.
- Avadel Pharmaceuticals' Deferred Taxes fell 292.46% to -$51.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$26.0 million, marking a year-over-year decrease of 266.12%. This contributed to the annual value of -$26.0 million for FY2022, which is 266.12% down from last year.
- As of Q4 2022, Avadel Pharmaceuticals' Deferred Taxes stood at -$51.9 million, which was down 113,015.22% from $46,000 recorded in Q3 2022.
- In the past 5 years, Avadel Pharmaceuticals' Deferred Taxes registered a high of $30.2 million during Q2 2022, and its lowest value of -$51.9 million during Q4 2022.
- For the 3-year period, Avadel Pharmaceuticals' Deferred Taxes averaged around -$244,000, with its median value being -$3.1 million (2021).
- In the last 5 years, Avadel Pharmaceuticals' Deferred Taxes tumbled by 3,701.80% in 2020 and then surged by 917.35% in 2022.
- Over the past 4 years, Avadel Pharmaceuticals' Deferred Taxes (Quarterly) stood at $5.0 million in 2019, then skyrocketed by 140.21% to $12.0 million in 2020, then spiked by 124.66% to $27.0 million in 2021, then slumped by 292.46% to -$51.9 million in 2022.
- Its last three reported values are -$51.9 million in Q4 2022, $46,000 for Q3 2022, and $30.2 million during Q2 2022.